Daré Bioscience, Inc. DARE

Full chart Compare
Set alert

Price alert · DARE

All alert types
0.63 USD -0.02 (-3.73%)

Nov 3, 2026, 3:21 PM EST

0.6201 Day range 0.66
0.6201 52-week range 3.78
YTD
-67.33%
1 year
-67.16%

Analyst view

Consensus: buy

Buy
Price target (mean) 21.33 +3283.0% upside
Target (low)
12.00
Target (mean)
21.33
Target (high)
39.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DARE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.63333-0.80 – -0.52-0.72+12.0%1.00M-44.7%3
Next quarter-0.65-0.76 – -0.54-0.84+22.6%0-100.0%2
Current year-0.46-0.63 – -0.34-4.20+89.0%1.05M-62.4%3
Next year-2.01-2.38 – -1.42-0.46-337.7%2.45M+132.4%3

Upgrades and downgrades

The latest rating changes

DARE analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 16, 2024Jones TradingMaintainedBuyBuy
Aug 14, 2024Maxim GroupDowngradeBuyHold
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2024Brookline CapitalUpgradeHoldBuy
May 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 17, 2024Brookline CapitalDowngradeBuyHold
Apr 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 10, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 6, 2023HC Wainwright & Co.Reiterated—Buy
May 22, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 31, 2023HC Wainwright & Co.Reiterated—Buy
Dec 13, 2022HC Wainwright & Co.Maintained—Buy
Dec 1, 2022JonesTradingInitiated—Buy
Apr 1, 2022HC Wainwright & Co.Maintained—Buy
Jun 30, 2021Roth CapitalMaintained—Buy
Dec 18, 2020HC Wainwright & Co.Initiated—Buy
Apr 28, 2020Brookline CapitalInitiated—Buy
Aug 17, 2018Maxim GroupInitiated—Buy